Literature DB >> 21944869

Protein kinase C-theta in platelet activation.

Sagit Cohen1, Alex Braiman, George Shubinsky, Noah Isakov.   

Abstract

Members of the protein kinase C (PKC) family of serine/threonine kinases have been implicated in several physiological processes regulating the activation response of platelets. They are involved in processes leading to granule secretion, integrin activation, platelet aggregation and spreading, and procoagulation. The protein kinase C θ (PKCθ) isoform, which was originally identified in T lymphocytes, is also expressed at relatively high levels in platelets, wherein it is involved in the regulation of hemostasis and thrombosis. Recent studies suggest a role for PKCθ in protease-activated receptor (PAR)-, glycoprotein VI (GPVI) receptor- and glycoprotein α(IIb)β(3) integrin receptor-linked signal transduction pathways. The present review focuses on the latest observations relevant to the role of PKCθ in platelet activation.
Copyright © 2011. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21944869     DOI: 10.1016/j.febslet.2011.09.014

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  13 in total

1.  The Src family kinases and protein kinase C synergize to mediate Gq-dependent platelet activation.

Authors:  Binggang Xiang; Guoying Zhang; Lucia Stefanini; Wolfgang Bergmeier; T Kent Gartner; Sidney W Whiteheart; Zhenyu Li
Journal:  J Biol Chem       Date:  2012-10-12       Impact factor: 5.157

Review 2.  Polyphenol compounds and PKC signaling.

Authors:  Joydip Das; Rashmi Ramani; M Olufemi Suraju
Journal:  Biochim Biophys Acta       Date:  2016-06-29

3.  Extracellular vesicle-driven information mediates the long-term effects of particulate matter exposure on coagulation and inflammation pathways.

Authors:  Sofia Pavanello; Matteo Bonzini; Laura Angelici; Valeria Motta; Laura Pergoli; Mirjam Hoxha; Laura Cantone; Angela Cecilia Pesatori; Pietro Apostoli; Armando Tripodi; Andrea Baccarelli; Valentina Bollati
Journal:  Toxicol Lett       Date:  2016-08-06       Impact factor: 4.372

4.  mTOR regulates GPVI-mediated platelet activation.

Authors:  Longsheng Wang; Gang Liu; Nannan Wu; Baiyun Dai; Shuang Han; Qiaoyun Liu; Fang Huang; Zhihua Chen; Weihong Xu; Dajing Xia; Cunji Gao
Journal:  J Transl Med       Date:  2021-05-10       Impact factor: 5.531

5.  Intervention of PKC-θ as an immunosuppressive regimen.

Authors:  Zuoming Sun
Journal:  Front Immunol       Date:  2012-08-02       Impact factor: 7.561

Review 6.  Chemical proteomics: terra incognita for novel drug target profiling.

Authors:  Fuqiang Huang; Boya Zhang; Shengtao Zhou; Xia Zhao; Ce Bian; Yuquan Wei
Journal:  Chin J Cancer       Date:  2012-05-23

7.  Embelin as a Novel Inhibitor of PKC in the Prevention of Platelet Activation and Thrombus Formation.

Authors:  Jiun Yi Li; Ray Jade Chen; Li Ting Huang; Tzu Yin Lee; Wan Jung Lu; Kuan Hung Lin
Journal:  J Clin Med       Date:  2019-10-18       Impact factor: 4.241

8.  Integrin αIIbβ3 outside-in signaling activates human platelets through serine 24 phosphorylation of Disabled-2.

Authors:  Hui-Ju Tsai; Ju-Chien Cheng; Man-Leng Kao; Hung-Pin Chiu; Yi-Hsuan Chiang; Ding-Ping Chen; Kun-Ming Rau; Hsiang-Ruei Liao; Ching-Ping Tseng
Journal:  Cell Biosci       Date:  2021-02-08       Impact factor: 7.133

9.  Newer agents in antiplatelet therapy: a review.

Authors:  Jennifer Yeung; Michael Holinstat
Journal:  J Blood Med       Date:  2012-06-25

10.  VAS2870 and VAS3947 attenuate platelet activation and thrombus formation via a NOX-independent pathway downstream of PKC.

Authors:  Wan Jung Lu; Jiun Yi Li; Ray Jade Chen; Li Ting Huang; Tzu Yin Lee; Kuan Hung Lin
Journal:  Sci Rep       Date:  2019-12-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.